Annie McGuire
Ufficiale delle Risorse Umane presso VERACYTE, INC.
Patrimonio netto: 2 M $ in data 30/06/2024
Profilo
Ms. Annie McGuire is a Chief People Officer, EVP & General Counsel at Veracyte, Inc. Ms. McGuire was previously employed as a Secretary & General Counsel by Rakuten Medical, Inc., a Vice President-Legal by MyoKardia, Inc., and a Senior Corporate Counsel by Amgen, Inc. She received her undergraduate degree from Pace University and a graduate degree from New York Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VERACYTE INC
0.12% | 02/06/2024 | 95 406 ( 0.12% ) | 2 M $ | 30/06/2024 |
Posizioni attive di Annie McGuire
| Società | Posizione | Inizio |
|---|---|---|
| VERACYTE, INC. | Ufficiale delle Risorse Umane | - |
Precedenti posizioni note di Annie McGuire
| Società | Posizione | Fine |
|---|---|---|
Rakuten Medical, Inc.
 Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Consigliere Generale | 01/02/2022 |
| MYOKARDIA, INC. | Corporate Officer/Principal | 01/04/2021 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Annie McGuire
| New York Law School | Graduate Degree |
| Pace University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VERACYTE, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Rakuten Medical, Inc.
Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Commercial Services |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Annie McGuire
